2023 was a tough year in many ways, but saw significant positive developments in science and medicine, Washington Post reports
2023 saw new understanding and the start of a treatment
for dementia, as clinical trials cotinue at the University
of Kentucky and other sites. (iStock photo via Washington Post)
|
The Food and Drug Administration approved the first pill to treat postpartum depression, which affects up to one in five womenand can cause “experience intense hopelessness and, in rare cases, psychosis — and it can last for years,” the Post notes. “The new drug is taken once a day for two weeks and, unlike the existing treatment of an IV injection that may take as long as 60 hours to administer in a health-care setting, it can be taken at home.”
Meanwhile, the FDA approved, for the first time, to a drug that modestly slows Alzheimer’s disease. While difficult questions about safety, effectiveness and cost remain, many neurologists say that having a drug that slows Alzheimer’s is nonetheless a milestone after years of failed trials. The University of Kentucky is one of the sites of the clinical trials, and at last report was still seeking participants.
Kentucky Health News is an independent news service of the Institute for Rural Journalism and Community Issues, based in the School of Journalism and Media at the University of Kentucky, with support from the Foundation for a Healthy Kentucky.
Donate to Kentucky Health News here.
http://kyhealthnews.blogspot.com/2023/12/2023-tough-year-in-many-ways-saw.html
Recommended Posts
Public had wide-ranging opinions about urban growth master plan in Fayette County
Thu, October 17, 2024
Trump courts Latino voters at Univision town hall, and Harris ventures onto Fox News
Thu, October 17, 2024
Lextran offering free rides on Election Day
Thu, October 17, 2024